Showing 431-440 of 5607 results for "".
Physician Assistants: What's in a Name?
https://reachmd.com/programs/clinicians-roundtable/physician-assistants-whats-in-a-name/4472/Does the title Physician Assistant truly capture the core of the PA's role in the 21st century? Does the title hinder efforts to advance the role of the PA profession? Is the word "assistant" confusing to patients, doctors and other healthcare professionals? Those are just a few of the questions expReviewing the National Cancer Institute Budget
https://reachmd.com/programs/clinicians-roundtable/reviewing-the-national-cancer-institute-budget/453/Host Paul Raeburn interviews Susan Dentzer, an on-air correspondent for The News Hour with Jim Lehrer, about the NCI budget. It's flat this year and that means less money for cancer research.Navigating the Crisis: How to Diagnose and Treat Malignant Hyperthermia
https://reachmd.com/programs/clinicians-roundtable/navigating-the-crisis-how-to-diagnose-and-treat-malignant-hyperthermia/18111/Here’s what you need to know about diagnosing and treating malignancy hyperthermia.Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
https://reachmd.com/programs/neurofrontiers/modern-ms-care-navigating-treatment-options-for-better-patient-outcomes/36362/Since 2010, the landscape of multiple sclerosis care has transformed to encompass a variety of medications, each having unique benefits, risks, and side effect profiles. Dr. Jonathan Howard discusses how to match treatment strength to disease severity and balance patient risk tolerance with evolvingThe National Campaign to Recognize Female Sexual Dysfunction
https://reachmd.com/programs/clinicians-roundtable/the-national-campaign-to-recognize-female-sexual-dysfunction/7207/Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr.Brain Research & National Defense: How Sleep, Beta Blockers, and Hallucinogens Can Aid the Military
https://reachmd.com/programs/clinicians-roundtable/brain-research-national-defense-how-sleep-beta-blockers-and-hallucinogens-can-aid-the-military/2968/Host Dr. Larry Kaskel talks with medical ethicist and author Dr. Jonathon Moreno about uses of newer brain research in supporting our military. They discuss the impact of sleep deprivation, performance enhancing drugs and hallucinogens. They also consider the use of beta blockers to prevent or reducNavigating Vaccine Communication: A Medical Affairs Perspective
https://reachmd.com/programs/maps-chats/vaccine-communication-medical-affairs/56810/At the intersection of expertise, strategy, and collaboration, medical affairs professionals are translating vaccine science into meaningful and actionable insights for healthcare providers. In this candid conversation from the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting, Dr. MatInsights into the Natural History of Patients with Dravet Syndrome from the BUTTERFLY Study
https://reachmd.com/programs/practical-neurology/insights-into-the-natural-history-of-patients-with-dravet-syndrome-from-the-butterfly-study/39911/Navigating Fertility Preservation in Young Patients With Endometrial Cancer
https://reachmd.com/programs/project-oncology/navigating-fertility-preservation-in-young-patients-with-endometrial-cancer/36397/Endometrial cancer is increasingly affecting younger patients, many of whom wish to preserve fertility—a challenge compounded by limited access to assisted reproductive technologies. Dr. Kathleen Moore explores established fertility-sparing regimens, including hormonal therapies and IUD-basedNavigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
https://reachmd.com/programs/project-oncology/akt-inhibitor-ae-hr-positive-her2-negative-bc/54762/AKT inhibition offers a targeted approach to overcoming endocrine resistance in HR+/HER2- advanced breast cancer. However, treatment is associated with adverse events like hyperglycemia, rash, and diarrhea. In this conversation with Dr. Alexandria May, Dr. Adam Brufsky outlines how to assess baselin